Chromogranin A (CgA) and Pancreastatin (PcSt) as Predictors of Peptide Receptor Radionuclide Therapy (PRRT) Outcomes in Patients with Metastatic Well-Differentiated Neuroendocrine Tumors (mNETs) Abstract #439

Introduction: CgA and PcSt are widely used in assessing response to treatment in mNETs.
Aim(s): To study the role of pre PRRT levels of CgA and PcSt on overall survival (OS) and median time to progression (mTTP).
Materials and methods: One-hundred and thirty-five cases from the University of Iowa NET database were analyzed and survival calculated.
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: Nancy Sharma

To read results and conclusion, please login ...

Further abstracts you may be interested in

No result